A Locke Lord team led by Nick Jennings (London) represented BSF Enterprise PLC in connection with its acquisition of 3D Bio-Tissues Limited, a tissue engineering business based in Newcastle, UK (constituting a reverse takeover), waiver or Rule 9 of the Takeover Code, its placing of new ordinary shares and admission of the enlarged share capital to the Main Market of the London Stock Exchange. BSF is unlocking the next generation of biotech solutions to drive the development of lab-grown tissues. For more information, see the press release. Additional assistance was provided by Charlotte Whitley-Roberts (London).
Posted on May 22, 2022